BTIG Cuts GE HealthCare Technologies (GEHC) Price Target to $75

BTIG has reaffirmed a Buy rating on GE HealthCare, lowering its price target to $75, a 7.54% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:16 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

BTIG cut its price target on GE HealthCare Technologies Inc. ($GEHC) to $75 from $79 on October 12, 2026, and rates the stock "Buy".

Since the rating, $GEHC is up 2.7% to date (from the $67.74 close on Oct 12, 2026).

GEHC GE HealthCare Technologies Inc.

$69.57 -15.88% year to date

Daily close · Oct 16, 2026

Key Points

On October 12, 2026, BTIG reiterated its Buy rating on GE HealthCare Technologies Inc. (GEHC) with a new price target of $75, down from $79.
BTIG's $75 price target implies 7.54% upside from GE HealthCare Technologies Inc.'s ($GEHC) current $69.74 share price.
The stock recently traded around $69.74, which is about 7% below BTIG's new target.
GE HealthCare reported a trailing twelve-month revenue of approximately $21.3 billion and has a dividend rate of $0.14.

Get $GEHC trade alerts by text

We text you when insiders, Congress or big funds trade $GEHC. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated GE HealthCare Technologies Inc. alert may contain errors. Disclosures

BTIG has reiterated its Buy rating on GE HealthCare Technologies Inc. (GEHC) with a new price target of $75 on October 12, 2026. This is a decrease from the previous target of $79. The stock is currently trading at about $69.74, which places it approximately 7% below BTIG's latest target.

Other Institutional Activity in GE HealthCare

Several other institutional investors have also been active in GE HealthCare. Dodge & Cox Inc. holds 37,864,164 shares worth about $2.63 billion, having increased its stake by 6,553,353 shares, a 20.9% increase. Blackrock Inc. owns 37,467,843 shares valued at approximately $2.61 billion, after adding 1,482,592 shares, a 4.1% increase. Vanguard Capital Management LLC has 29,724,359 shares worth around $2.07 billion, having increased its holdings by 860,153 shares, a 3.0% increase.

GE HealthCare Technologies Inc. Stock Up 8.7%

The shares of GE HealthCare are currently trading around $69.74. This price is near the lower end of the company's recent trading range, suggesting potential investor caution. The stock's recent performance may impact how investors view the company's prospects following BTIG's updated target.

12-month forecast

$GEHC price target

GE HealthCare Technologies Inc. daily closes and this analyst's $75 target. Not advice.

Recent Earnings

GE HealthCare reported trailing twelve-month revenue of about $21.3 billion, with a net margin of 9.3% and a return on equity of 19.4%. The company is scheduled to announce its next earnings on October 28, 2026.

Insider Buying and Selling at GE HealthCare Technologies Inc.

Insider transactions show some activity at GE HealthCare. Director Henry Lawrence Culp Jr. bought 80,805 shares at an average price of $61.88 on May 6, 2026, totaling about $5 million. Director Watkin Phoebe L Yang purchased 1,000 shares at $63.01 on May 8, 2026, valued at $63,006. Additionally, Director Rodney F Hochman acquired 1,618 shares at an average price of $62.03 on May 12, 2026, for about $100,365. Director Kevin A Lobo also bought 10,000 shares at $64.18 on May 22, 2026, totaling approximately $641,800.

Analysts Set New Price Targets

On October 12, 2026, BTIG maintained its Buy rating on GE HealthCare with a target price of $75, down from $79. Other recent analyst activity includes Needham initiating coverage with a Buy rating and a target of $93 on September 22, 2026, and Citigroup maintaining a Neutral rating with a target of $71, down from $75, on October 5, 2026. The consensus among analysts suggests a cautious outlook as the average target remains above the current trading price.

About GE HealthCare

GE HealthCare Technologies Inc. focuses on developing, manufacturing, and marketing products for diagnosing, treating, and monitoring patients. The company operates in various segments, including Imaging and Patient Care Solutions. With a diverse range of medical devices and services, GE HealthCare plays a crucial role in the healthcare sector.

Bottom Line

Investors should keep an eye on GE HealthCare's upcoming earnings report on October 28, 2026, and further analyst updates following BTIG's recent rating adjustment. The stock's performance relative to the new target price will be important for assessing market sentiment.